Lupin Pharmaceuticals has announced the launch of the InspiraChamber valved holding chamber after it acquired exclusive US rights to the device from InspiRX. The InspiraChamber is being sold as part of a package with pediatric face masks, including the SootherMask, which has a slot for a pacifier.
InspiRX CEO Michael Amato commented, “The agreement enables the commercialization of InspiraChamber in the US. Furthermore, and given Lupin’s brand equity within the US pediatric community, the launch ensures that the product reaches children, infants and toddlers – an age demographic which we feel needs a product like InspiraChamber a VHC that ensures better and more effective drug delivery.”
Lupin Limited CEO Vinita Gupta said, “We are very excited with the addition of InspiraChamber VHC to our Brand business portfolio. The launch demonstrates Lupin’s commitment to grow its brand franchise in the US and bring meaningful products to patients in the country. The launch also heralds Lupin’s entry into the larger US inhalation and related markets.”
Earlier this week, Lupin announced that it had entered into an agreement with Celon Pharmaceuticals for development of a generic version of Advair Diskus for the US market.
Read the Lupin press release.
